# A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy

> **NCT05303558** · — · COMPLETED · sponsor: **Johnson & Johnson International (Singapore) Pte. Ltd.** · enrollment: 221 (actual)

## Conditions studied

- High Risk Localized Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05303558
- **Lead sponsor:** Johnson & Johnson International (Singapore) Pte. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-24
- **Primary completion:** 2023-06-07
- **Final completion:** 2023-06-07
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2024-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303558, "A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05303558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*